+ Site Statistics
+ Resolve Accession
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
Submit PDF Full TextSubmit PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Preparation of radio labeled thyroid stimulating immuno globulins by recombining thyroid stimulating immuno globulins heavy chains with iodine 125 labeled light chains direct evidence that the product binds to the membrane thyrotropin receptor and stimulates adenylate cyclase

, : Preparation of radio labeled thyroid stimulating immuno globulins by recombining thyroid stimulating immuno globulins heavy chains with iodine 125 labeled light chains direct evidence that the product binds to the membrane thyrotropin receptor and stimulates adenylate cyclase. Endocrinology 103(1): 296-301

The biologically active portion of the thyroid-stimulating immunoglobulin (TSI/LATS [long acting thyroid stimulator] molecule is in the Fd portion of the heavy (H) chain. Radioiodination of TSI/LATS by the chloramine T method or contact with the oxidant only results in reduction and/or abolition of its biological activity in vivo. Such treatment also results in a loss of thyroid membrane adenylate cyclase stimulatory activity. A method for labeling TSI was devised which circumvents contact of the H chain with oxidant or radioiodine. The H and L [light] chains of TSI were separated by mild reduction, alkylation and gel filtration in 1 M propionic acid. The separated TSI H chains were then mixed with .kappa.-type Bence-Jones L chains (molar ratio, 1:2) which were previously iodinated by 125I (*L) or 127I (.degree.L), and Ig[immunoglobulin]G was reconstituted by dialysis of the mixture in 10 mM sodium acetate buffer, pH 5.5 IgG was then separated from free H and L chains by gel filtration. The IgG (*L-TSI or .degree.L-TSI) thus contained iodinated L chains, whereas all of the unlabeled H chains were from the original TSI source. After incubation of *L-TSI with human thyroid membranes for 3 h at C in 10 mM Tris-HCl buffer, pH 7.4, containing 30 mM NaCl and 0.5% bovine serum albumin, 1-2% was specifically bound to membranes. This binding could be inhibited by unlabeled TSI and bovine TSH [thyrotropin]. Both .degree.L-TSI and native TSI stimulated thyroid membrane adenylate cyclase and inhibited [125I]bovine TSH binding to membranes in a dose-related fashion; native TSI which was iodinated directly no longer had either property. TSI apparently binds to TSH receptors on thyroid cell membranes and stimulates adenylate cyclase activity. The method offers the potential to obtain membrane-purified and radiolabeled TSI for further biochemical, physiological and clinical studies.

(PDF 0-2 workdays service)

Order PDF Full Text


Click here to order any other PDF Full Text

Accession: 006173770

PDF Full Text: Submit

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Other references

Holmes, P., 1987: New treatments for impotence. Nursing Times 83(34): 42-43

Kirner, S.H.; Barbehenn, KR.; Travis, B.V., 1955: A summer survey of the blood parasites of two Microtus pennsylvanicus populations, Ithaca. NY J Parasit Suppl, 41: 14

Jeong, H.; Kim, Y-Ri.; Kim, K-Nam.; Choe, J-Gol.; Chung, J-Key.; Kim, M-Kon., 2006: Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line. The plasma membrane glycoprotein sodium/iodide symporter (NIS) is crucial for thyroid hormone biosynthesis and mediates the iodide uptake of thyrocytes. It has been shown that retinoic acid (RA) alters NIS gene expression in thyroid carcinoma line...

Chopin D.K.; Antiphon P.M.; Abbou C.C.; Denis B.R.; Auvert J.M., 1986: Evaluation of continence after bladder replacement by entero uretero urethrostomy for bladder cancer. Journal of Urology 135(4 PART 2): 263A

Jesse, R.; Deeg, P.; Schneider, K.W., 1975: A modified technique for transseptal angiocardiography: review of 186 cases. Perforations of the left atrial or ventricular wall and extravasations of contrast medium during transseptal left heart catheterisation or angiocardiography can be eliminated by replacing the normally used transseptal catheters by Pigtail-catheter...

Rastogi, S.; Agarwal, P.; Krishnan, M.Y., 2016: Use of an adipocyte model to study the transcriptional adaptation of Mycobacterium tuberculosis to store and degrade host fat. During its persistence in the infected host, Mycobacterium tuberculosis (Mtb) accumulates host-derived fatty acids in intracytoplasmic lipid inclusions as triacylglycerols which serve primarily as carbon and energy reserves. The Mtb genome codes f...

Lindsey, J., 2004: Road safety vehicle simulator--just like the real thing!. Jems 29(7): 92-93

Matulonis, U.A., 2011: Bevacizumab and its use in epithelial ovarian cancer. Bevacizumab is a monoclonal antibody that binds to VEGF, a circulating protein involved in the promotion of angiogenesis and probably tumor growth and progression. Bevacizumab has demonstrated anticancer activity in several cancers, either combine...

Goth, R.; Zaumeyer, W., 1968: Cucumber mosaic virus on lima beans. Annual report: no 11 24

Lacerda, A.E.; Kuryshev, Y.A.; Chen, Y.; Renganathan, M.; Eng, H.; Danthi, S.J.; Kramer, J.W.; Yang, T.; Brown, A.M., 2007: Alfuzosin delays cardiac repolarization by a novel mechanism. The United States Food and Drug Administration (FDA) uses alfuzosin as an example of a drug having QT risk in humans that was not detected in nonclinical studies. FDA approval required a thorough clinical QT study (TCQS) that was weakly positive a...